Skip to main content
Tech.euFundingExplorerBeta

Cardea Bio

Exited

Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit).

Total raised
€0
€0
Funding rounds
0
Investors
0
distinct backers
Active since

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
May 2023
Value
Acquiror
Paragraf (UK)

Related news

Similar companies

same sector or country